Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Precision Medicine Based on the Achievement of Sustained Undetectable Minimal Residual Disease (MRD) By Next-Generation Flow (NGF) and Imaging Leads to Significant Reduction in Risk of Progression of Patients with Multiple Myeloma (MM)

Jose Enrique De La Puerta Rueda, MD, Leire Burgos, Garazi Letamendi Madariaga, MD, Cristina Martinez Bilbao, MD, Luis Atutxa Aresti, MD, Jesus Ojanguren Bergaz, MD, Matxalen Olivares Salaverri, MD, Begoña Sancho Garaizabal, MD, Isabel Uriarte, MD, Iñigo Vicente Olabarria, MD, Raquel Pérez Garay, MD, Ana de Juan Arroyo, Pharm, Itxaso Amarika Ibarrondo, MD, Tomas Carrascosa Vallejo, MD, Amaia Casado Diez, MD, Cristina Cortes Fernández, MD, Ianire Etxeguren Urkixo, MD, Eukene Gainza González, MD, Inés González Vallejo, MD, Javier Goikolea Ugarte, Pharm, Inmaculada Barredo Santamaría, MD, Alberto Sáiz López, MD, Antonio Vázquez Rodríguez, MD, Eloisa Urrechaga Igartua, MD, Maria José Ereño Ealo, MD, Estibalitz Montejo Rodrigo, MD, Elixabete Pastor Ausin, MD, Alberto Cabrera Zubizarreta, MD, José María Ontañón Garcés, MD, Ibone Saralegui Prieto, MD, Natalia Maruri Machado, MD, Paula Arana Berganza, MD, Mara Celis Alvarez, MD, Ane Aranbarri Larrañaga, MD, Paloma Ibarrondo Chamorro, MD, Bruno Paiva, PhD

Blood (2019) 134 (Supplement_1): 3170.

https://doi.org/10.1182/blood-2019-125062

Published: 2019

Journal Articles

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Michiho Ebihara, MD, Shinsuke Takagi, Yoshikazu Uesaka, MD PhD, Takashi Mitsuki, MD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Yukako Koike, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Atsushi Wake, MD PhD, Naoyuki Uchida, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2018) 132 (Supplement 1): 3390.

https://doi.org/10.1182/blood-2018-99-116308

Published: 2018

Journal Articles

Functional Cure, Defined As PFS of More Than 7 Years, Is Achieved in 9% of Myeloma Patients in the Era of Conventional Chemotherapy and of First-Generation Novel Anti-Myeloma Agents; A Single-Center Experience over 20-Year Period

Evangelos Terpos, MD PhD, Maria Roussou, MD, Ioannis Ntanasis-Stathopoulos, MD, Nikolaos Kanellias, MD, Despina Fotiou, MD, Dimitrios C. Ziogas, MD, Aristea-Maria Papanota, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Maria Gavriatopoulou, MD, Efstathios Kastritis, MD, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 1968.

https://doi.org/10.1182/blood-2018-99-113108

Published: 2018

Journal Articles

Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenström Macroglobulinaemia/ Lymphoplasmacytic Lymphoma

Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Tara Cochrane, MBBS, John Gibson, Nada Hamad, MBBS, BSc, MSc, Phoebe Joy Ho, MBBS DPhil FRACP FRCPA, Samar Issa, FRACP, Kwok Fiona, Jun Hee Lim, PhD, David Simpson, MBChB, FRACP, FRCPA, Constantine Tam, MD PhD, Jorge J. Castillo, MD

Blood (2018) 132 (Supplement 1): 5325.

https://doi.org/10.1182/blood-2018-99-113969

Published: 2018

Journal Articles

Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma

Vassilis Koutoulidis, Evangelos Terpos, MD PhD, Ioannis Ntanasis-Stathopoulos, Flora Zagouri, Ioanna Klapa, Andriani Boultadaki, Maria Gavriatopoulou, Sophia Fontara, Eftathios Kastritis, Meletios A. Dimopoulos, Lia A. Moulopoulos

Blood (2017) 130 (Supplement 1): 4404.

https://doi.org/10.1182/blood.V130.Suppl_1.4404.4404

Published: 2017

Journal Articles

Incidence and Differential Diagnosis of Human Herpes Virus-6 Associated Encephalitis/Myelitis in Allogeneic Stem Cell Transplantation That Mimics Calcineurin Inhibitor-Induced Pain Syndrome

Goichi Yoshimoto, MDPhD, Toshihiro Miyamoto, MD PhD, Koji Kato, MD PhD, Yasuo Mori, MDPhD, Kenjiro Kamezaki, MDPhD, Katsuto Takenaka, MDPhD, Hiromi Iwasaki, MD PhD, Koichi Akashi, MD PhD

Blood (2015) 126 (23): 1912.

https://doi.org/10.1182/blood.V126.23.1912.1912

Published: 2015

Journal Articles

Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial

Blood (2015) 126 (23): 395.

https://doi.org/10.1182/blood.V126.23.395.395

Published: 2015

Journal Articles

A Novel Case of Direct Antiglobulin Test-Negative Intravascular Hemolysis in a Patient with Smoldering Myeloma

Selina Dobing, MD BSc, Nikolas Desilet, MD BSc, Irwindeep Sandhu, MD, Lauren Bolster, MD MD FRCPC

Blood (2015) 126 (23): 4539.

https://doi.org/10.1182/blood.V126.23.4539.4539

Published: 2015

Journal Articles

Validation of the Novel Criteria for the Definition of Symptomatic Myeloma: A Single Center Experience in 216 Patients with the Previous Diagnosis of Asymptomatic Disease

Efstathios Kastritis, MD, Evangelos Terpos, Maria Roussou, Vassilis Koutoulidis, Stavroula Giannouli, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Despoina Fotiou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Kalapanida, Eirini Katodritou, Kostas Konstantopoulos, Lia A. Moulopoulos, Meletios A. Dimopoulos

Blood (2015) 126 (23): 4251.

https://doi.org/10.1182/blood.V126.23.4251.4251

Published: 2015

Journal Articles

Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial

Blood (2014) 124 (21): 3359.

https://doi.org/10.1182/blood.V124.21.3359.3359

Published: 2014

Journal Articles

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Evangelos Terpos, Nikolaos Kanellias, Lia A Moulopoulos, Dimitrios Christoulas, Andreas Koureas, Tina Bagratuni, Vasilios Koutoulidis, Efstathios Kastritis, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3090.

https://doi.org/10.1182/blood.V122.21.3090.3090

Published: 2013

Journal Articles

High C-Terminal Cross-Linking Telopeptide of Collagen Type-I (CTX) Predicts for Poor Overall Survival in Patients with Multiple Myeloma Who Receive Frontline Therapy with Immunomodulatory Drugs (IMiDs) but Not with Bortezomib-Based Regimens

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Athanasios Papatheodorou, Nikolaos Kanellias, Magdalini Migkou, Maria Gavriatopoulou, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Lia A Moulopoulos, Meletios A Dimopoulos, MD

Blood (2012) 120 (21): 935.

https://doi.org/10.1182/blood.V120.21.935.935

Published: 2012

Journal Articles

High Levels of Periostin in Patients with Multiple Myeloma Correlate with Low Bone Formation, Increased Fracture Rate and Diffuse MRI Pattern; Implications Into the Biology of Myeloma Bone Disease

Evangelos Terpos, Dimitrios Christoulas, Tina Bagratuni, Athanasios Papatheodorou, Maria Gkotzamanidou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Christina Liakou, Lia A Moulopoulos, Efstathios Kastritis, Meletios A Dimopoulos, MD

Blood (2012) 120 (21): 3967.

https://doi.org/10.1182/blood.V120.21.3967.3967

Published: 2012

Journal Articles

Extensive Bone Marrow Infiltration and Abnormal Free Light Chain Ratio Identifies Patients with Smoldering Myeloma At High Risk for Progression to Symptomatic Disease,

Efstathios Kastritis, Lia A Moulopoulos, Maria Gkotzamanidou, Dimitra Gika, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 3926.

https://doi.org/10.1182/blood.V118.21.3926.3926

Published: 2011

Journal Articles

Acquired Hemophilia Associated with Smoldering Myeloma: Demonstration That the Monoclonal Gammopathy Acts as the Factor VIII Inhibitor.

Olivier Decaux, Benoit Guillet, Arnaud Millet, Stephen Harding, Arthur R. Bradwell, Bernard Grosbois, Patrick Jego

Blood (2009) 114 (22): 1307.

https://doi.org/10.1182/blood.V114.22.1307.1307

Published: 2009

Journal Articles

Diffuse MRI Marrow Pattern Correlates with Increased Angiogenesis, Advanced Disease Features and Poor Prognosis in Newly-Diagnosed Patients with Multiple Myeloma Treated with Novel Agents.

Lia A. Moulopoulos, Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Dimitra Anagnostou, Andreas Koureas, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Marina Iakovaki, Maria Gkotzamanidou, Vasilios Skiadas, Anna Tasidou, Meletios A. Dimopoulos

Blood (2009) 114 (22): 829.

https://doi.org/10.1182/blood.V114.22.829.829

Published: 2009

Journal Articles

Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.

Patrizia Tosi, M.D., Alessandro Petrucci, M.D., Lucia Pantani, M.D., Elena Zamagni, Paola Tacchetti, M.D., Giulia Perrone, M.D., Annamaria Brioli, M.D., Michela Ceccolini, M.D., Michele Baccarani, MD, Michele Cavo, MD

Blood (2009) 114 (22): 4885.

https://doi.org/10.1182/blood.V114.22.4885.4885

Published: 2009

Journal Articles

Percutaneous Vertebroplasty to Treat Painful Myelomatous Vertebral Deposits: Long Term Efficacy Outcomes.

Paula Garland, MBBS, MSci, MRCP, Phillip Gishen, FRCR, DMRD(London), MBBCh, Amin Rahemtulla, MBBS, PhD, FRCP

Blood (2009) 114 (22): 1860.

https://doi.org/10.1182/blood.V114.22.1860.1860

Published: 2009

Journal Articles

Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.

Patrizia Tosi, MD, Elena Zamagni, MD, Paola Tacchetti, MD, Eugenio Salizzoni, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Annamaria Brioli, MD, Maria C. Pallotti, MD, Lucia Pantani, MD, Antonio de Vivo, MD, Michele Baccarani, MD, Michele Cavo, MD

Blood (2007) 110 (11): 4728.

https://doi.org/10.1182/blood.V110.11.4728.4728

Published: 2007

Journal Articles

Prognostic Significance of Magnetic Resonance Imaging (MRI) of Bone Marrow (BM) in Patients with Multiple Myeloma (MM) Undergoing Treatment with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplantation (ASCT).

Athanasios Anagnostopoulos, MD, Lia A. Moulopoulos, M.D., Maria Roussou, M.D., Efstathios Kastritis, M.D., Dimitra Gika, George Bozas, M.D., Aikaterini Stefanoudaki, M.D., Nikolaos Anagnostopoulos, M.D., Amalia Vassou, M.D., Konstantinos Bourantas, M.D., Meletios A. Dimopoulos, M.D.

Blood (2006) 108 (11): 3095.

https://doi.org/10.1182/blood.V108.11.3095.3095

Published: 2006

NARROW

Precision Medicine Based on the Achievement of Sustained Undetectable Minimal Residual Disease (MRD) By Next-Generation Flow (NGF) and Imaging Leads to Significant Reduction in Risk of Progression of Patients with Multiple Myeloma (MM)

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Functional Cure, Defined As PFS of More Than 7 Years, Is Achieved in 9% of Myeloma Patients in the Era of Conventional Chemotherapy and of First-Generation Novel Anti-Myeloma Agents; A Single-Center Experience over 20-Year Period

Bing Neel Syndrome: Retrospective Australasian Experience of a Rare Treatable Complication of Waldenström Macroglobulinaemia/ Lymphoplasmacytic Lymphoma

Diffuse Medullary Hyperdensities of the Femora and Humeri on Whole-Body Low-Dose Computed Tomography Identify Diffuse MRI Pattern of Involvement and Correlate with Advanced Disease Stage in Patients with Multiple Myeloma

Incidence and Differential Diagnosis of Human Herpes Virus-6 Associated Encephalitis/Myelitis in Allogeneic Stem Cell Transplantation That Mimics Calcineurin Inhibitor-Induced Pain Syndrome

Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial

A Novel Case of Direct Antiglobulin Test-Negative Intravascular Hemolysis in a Patient with Smoldering Myeloma

Validation of the Novel Criteria for the Definition of Symptomatic Myeloma: A Single Center Experience in 216 Patients with the Previous Diagnosis of Asymptomatic Disease

Prospective Evaluation of MRI and PET-CT at Diagnosis and before Maintenance Therapy in Symptomatic Patients with Multiple Myeloma Included in the IFM/DFCI 2009 Trial

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

High C-Terminal Cross-Linking Telopeptide of Collagen Type-I (CTX) Predicts for Poor Overall Survival in Patients with Multiple Myeloma Who Receive Frontline Therapy with Immunomodulatory Drugs (IMiDs) but Not with Bortezomib-Based Regimens

High Levels of Periostin in Patients with Multiple Myeloma Correlate with Low Bone Formation, Increased Fracture Rate and Diffuse MRI Pattern; Implications Into the Biology of Myeloma Bone Disease

Extensive Bone Marrow Infiltration and Abnormal Free Light Chain Ratio Identifies Patients with Smoldering Myeloma At High Risk for Progression to Symptomatic Disease,

Acquired Hemophilia Associated with Smoldering Myeloma: Demonstration That the Monoclonal Gammopathy Acts as the Factor VIII Inhibitor.

Diffuse MRI Marrow Pattern Correlates with Increased Angiogenesis, Advanced Disease Features and Poor Prognosis in Newly-Diagnosed Patients with Multiple Myeloma Treated with Novel Agents.

Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.

Percutaneous Vertebroplasty to Treat Painful Myelomatous Vertebral Deposits: Long Term Efficacy Outcomes.

Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.

Prognostic Significance of Magnetic Resonance Imaging (MRI) of Bone Marrow (BM) in Patients with Multiple Myeloma (MM) Undergoing Treatment with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplantation (ASCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only